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1. main messages
Screening women aged 70-90 for osteoporosis followed by treatment with alendronate may be cost-•	
saving. Screening and treatment with raloxifene is not cost-effective.
Mass media campaigns to promote physical activity, already highly cost-effective based on effects via •	
cardiovascular disease, diabetes and cancer, become even more so if a small reduction in fracture risks is 
included.
 
 
2. background
Osteoporosis is characterised by low bone mineral density and micro architectural deterioration of bone 
tissue leading to an increase in bone fragility and risk of fracture. Hip fractures are the most important result of 
osteoporosis and falls; they frequently result in death. Given an aging population, the burden due to fractures 
in Australia is set to increase. We modelled the effects on fractures of the hip, spine, pelvis, clavicula/humerus 
(shoulder / upper arm), rib, wrist, hand, lower leg and foot.
   
3. interventions
Two strategies to prevent osteoporotic fractures can be distinguished: a mass strategy and a ‘high-risk’ strategy. 
The mass strategy is aimed at the entire population, the high-risk strategy at persons with osteoporosis or 
osteopenia (mild osteoporosis). We reviewed the literature to identify interventions that reduce the risk 
of osteoporosis-related fractures and are applicable in the Australian context. We report on two types of 
interventions: screening for osteoporosis followed by treatment with one of two types of drugs, and a mass 
media campaign to increase levels of physical activity.
screening and treatment of osteoporosis among women: 1. Opportunistic screening for osteoporosis 
by GPs, by means of BMD measurement (DXA) and treatment for 5 years with either alendronate (a 
bisphosphonate) 70 mg/week, or with raloxifene (a selective oestrogen receptor modulator) 60 mg daily, 
plus calcium 500 mg/day, and vitamin D if deficient. The target group is women aged 70 to 90.
Promotion of physical activity via mass media: 2. Media campaign to promote regular moderate-intensity 
physical activity (PA) targeting adults aged 25 to 60. The campaign makes use of television and print-media 
advertising, physician mail-outs and community-level support programs and strategies.
Other interventions worth further study include physical activity programmes targeting people with 
osteoporosis, environmental interventions that stimulate physical activity, prevention of falls by reducing 
psychotropic medication, adapting the home environment, cataract surgery or combinations of these, and 
(other) drugs.
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4. cHoice of comparator
Cost-effectiveness of the screening and treatment interventions is evaluated in comparison to a “do nothing” scenario. However, given 
low treatment rates for osteoporosis this is not much different from current practice. The physical activity intervention is evaluated in 
comparison to current practice. 
 
  
5. intervention cost-effectiveness
The screening programme will to lead to health gains and may be cost-saving when treatment is with alendronate. Screening in 
combination with raloxifene treatment is not cost-effective; all results are above the $50,000/DALY threshold (Figure 1). Though it is 
widely prescribed for osteoporosis, raloxifene has only been proven effective to prevent vertebral fractures but not hip fractures. A 
proven reduction in the risk of breast cancer cannot compensate for that.
Figure 1. Cost-effectiveness of screening for osteoporosis among women aged 70-90 and subsequent treatment with alendronate or 
raloxifene, compared to no intervention.
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Table 1. Cost-effectiveness and probability of being cost-saving or cost-effective of osteoporosis screening interventions
The physical activity intervention was already cost-saving based on its effect on cardiovascular disease, diabetes and cancer. (See ACE 
Prevention results on physical activity.) The fracture prevention-effect adds a modest 134 DALYs (+0.6%) and cost-savings of $4.5 million 
(7%). At older ages, when fracture risks are higher, the health gains from physical activity interventions are likely to be greater.
 
 
6. conclusions
Screening older women for osteoporosis followed by treatment with alendronate is effective and may be cost-saving. Screening and 
treatment with raloxifene is not cost-effective. Mass media campaigns to promote physical activity, already highly cost-effective based 
on effects via cardiovascular disease, diabetes and cancer, become even more so if a small reduction in fracture risks is included. The 
uptake of both interventions is likely to be greater among women with higher socio-economic status. Personnel shortages may limit the 
capacity for bone mineral density screening, especially in rural areas.
For more information on this topic area, please visit: www.sph.uq.edu.au/bodce-ace-prevention
Intervention Median ICER 
(95% uncertainty interval)
Probability of being 
cost-saving 
Probability of being 
under $50,000/DALY
Screening + 
alendronate 
Cost-saving 
(cost-saving  to $21,000) 63% 100% 
Screening + 
raloxifene 
$170,000 
(140,000  to 230,000) 0% 0% 
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7. about ace-prevention
To aid priority setting in prevention, the Assessing Cost-Effectiveness in Prevention Project (ACE-Prevention) applies 
standardised evaluation methods to assess the cost-effectiveness of 100 to 150 preventive interventions, taking a health 
sector perspective. This information is intended to help decision makers move resources from less efficient current 
practices to more efficient preventive action resulting in greater health gain for the same outlay.
indigenous population results 
1.   Cardiovascular disease prevention 
2.   Diabetes prevention 
3.   Screening and early treatment of chronic kidney disease
overall results 
1.   League table 
2.   Combined effects 
General population results 
1.    Adult depression 
2.    Alcohol 
3.    Blood pressure and cholesterol lowering 
4.    Cannabis 
5.    Cervical cancer screening, Sunsmart and PSA screening 
6.    Childhood mental disorders 
7.    Fruit and vegetables 
8.    HIV 
9.    Obesity 
10.  Osteoporosis 
11.   Physical activity 
12.   Pre diabetes screening 
13.   Psychosis 
14.   Renal replacement therapy, screening and early treatment of chronic kidney disease 
15.   Salt 
16.   Suicide prevention 
17.   Tobacco 
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